221 related articles for article (PubMed ID: 24852722)
1. Causes of variation in BCG vaccine efficacy: examining evidence from the BCG REVAC cluster randomized trial to explore the masking and the blocking hypotheses.
Barreto ML; Pilger D; Pereira SM; Genser B; Cruz AA; Cunha SS; Sant'Anna C; Hijjar MA; Ichihara MY; Rodrigues LC
Vaccine; 2014 Jun; 32(30):3759-64. PubMed ID: 24852722
[TBL] [Abstract][Full Text] [Related]
2. Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: second report of the BCG-REVAC cluster-randomised trial.
Barreto ML; Pereira SM; Pilger D; Cruz AA; Cunha SS; Sant'Anna C; Ichihara MY; Genser B; Rodrigues LC
Vaccine; 2011 Jul; 29(31):4875-7. PubMed ID: 21616115
[TBL] [Abstract][Full Text] [Related]
3. Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial.
Rodrigues LC; Pereira SM; Cunha SS; Genser B; Ichihara MY; de Brito SC; Hijjar MA; Dourado I; Cruz AA; Sant'Anna C; Bierrenbach AL; Barreto ML
Lancet; 2005 Oct; 366(9493):1290-5. PubMed ID: 16214599
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and cost-effectiveness of first BCG vaccination against tuberculosis in school-age children without previous tuberculin test (BCG-REVAC trial): a cluster-randomised trial.
Pereira SM; Barreto ML; Pilger D; Cruz AA; Sant'Anna C; Hijjar MA; Ichihara MY; Santos AC; Genser B; Rodrigues LC
Lancet Infect Dis; 2012 Apr; 12(4):300-6. PubMed ID: 22071248
[TBL] [Abstract][Full Text] [Related]
5. Design of the Brazilian BCG-REVAC trial against tuberculosis: a large, simple randomized community trial to evaluate the impact on tuberculosis of BCG revaccination at school age.
Barreto ML; Rodrigues LC; Cunha SS; Pereira S; Hijjar MA; Ichihara MY; de Brito SC; Dourado I
Control Clin Trials; 2002 Oct; 23(5):540-53. PubMed ID: 12392870
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong.
Leung CC; Tam CM; Chan SL; Chan-Yeung M; Chan CK; Chang KC
Int J Tuberc Lung Dis; 2001 Aug; 5(8):717-23. PubMed ID: 11495262
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature.
Colditz GA; Berkey CS; Mosteller F; Brewer TF; Wilson ME; Burdick E; Fineberg HV
Pediatrics; 1995 Jul; 96(1 Pt 1):29-35. PubMed ID: 7596718
[TBL] [Abstract][Full Text] [Related]
8. Design of the leprosy component of the Brazilian BCG revaccination trial for assessing BCG effectiveness against leprosy in school children.
Cunha SS; Dourado I; Barreto ML; Alexander N; Pereira SM; Ichihara Y; Pereira ES; Pedrosa V; Maroja F; Ribas C; Rodrigues LC
Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):8-15. PubMed ID: 15217320
[TBL] [Abstract][Full Text] [Related]
9. A case-control study of protection against tuberculosis by BCG revaccination in Recife, Brazil.
Dantas OM; Ximenes RA; de Albuquerque Mde F; da Silva NL; Montarroyos UR; de Souza WV; Pereira TC; Campelo AR; Rodrigues LC
Int J Tuberc Lung Dis; 2006 May; 10(5):536-41. PubMed ID: 16704036
[TBL] [Abstract][Full Text] [Related]
10. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
11. Neonatal BCG protection against tuberculosis lasts for 20 years in Brazil.
Barreto ML; Cunha SS; Pereira SM; Genser B; Hijjar MA; Yury Ichihara M; de Brito SC; Dourado I; Cruz A; Santa'Ana C; Rodrigues LC
Int J Tuberc Lung Dis; 2005 Oct; 9(10):1171-3. PubMed ID: 16229231
[TBL] [Abstract][Full Text] [Related]
12. On the impact of masking and blocking hypotheses for measuring the efficacy of new tuberculosis vaccines.
Arregui S; Sanz J; Marinova D; Martín C; Moreno Y
PeerJ; 2016; 4():e1513. PubMed ID: 26893956
[TBL] [Abstract][Full Text] [Related]
13. [Where do we stand with BCG vaccination programme in Japan?].
Mori T
Kekkaku; 2001 Apr; 76(4):385-97. PubMed ID: 11398330
[TBL] [Abstract][Full Text] [Related]
14. Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis.
Abubakar I; Pimpin L; Ariti C; Beynon R; Mangtani P; Sterne JA; Fine PE; Smith PG; Lipman M; Elliman D; Watson JM; Drumright LN; Whiting PF; Vynnycky E; Rodrigues LC
Health Technol Assess; 2013 Sep; 17(37):1-372, v-vi. PubMed ID: 24021245
[TBL] [Abstract][Full Text] [Related]
15. New tuberculosis vaccines in India: modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01
Clark RA; Weerasuriya CK; Portnoy A; Mukandavire C; Quaife M; Bakker R; Scarponi D; Harris RC; Rade K; Mattoo SK; Tumu D; Menzies NA; White RG
BMC Med; 2023 Aug; 21(1):288. PubMed ID: 37542319
[TBL] [Abstract][Full Text] [Related]
16. Influence of sex, age & nontuberculous infection at intake on the efficacy of BCG: re-analysis of 15-year data from a double-blind randomized control trial in South India.
Narayanan PR
Indian J Med Res; 2006 Feb; 123(2):119-24. PubMed ID: 16575109
[TBL] [Abstract][Full Text] [Related]
17. Neonatal BCG protection against leprosy: a study in Manaus, Brazilian Amazon.
Cunha SS; Rodrigues LC; Pedrosa V; Dourado IM; Barreto ML; Pereira SM
Lepr Rev; 2004 Dec; 75(4):357-66. PubMed ID: 15682973
[TBL] [Abstract][Full Text] [Related]
18. Influence of BCG vaccine strain on the immune response and protection against tuberculosis.
Ritz N; Hanekom WA; Robins-Browne R; Britton WJ; Curtis N
FEMS Microbiol Rev; 2008 Aug; 32(5):821-41. PubMed ID: 18616602
[TBL] [Abstract][Full Text] [Related]
19. The influence of bacille Calmette-Guerin vaccine strain on the immune response against tuberculosis: a randomized trial.
Ritz N; Dutta B; Donath S; Casalaz D; Connell TG; Tebruegge M; Robins-Browne R; Hanekom WA; Britton WJ; Curtis N
Am J Respir Crit Care Med; 2012 Jan; 185(2):213-22. PubMed ID: 22071384
[TBL] [Abstract][Full Text] [Related]
20. Neonatal revaccination with Bacillus Calmette-Guérin elicits improved, early protection against Mycobacterium tuberculosis in mice.
Li W; Huang H; Hua W; Ben S; Liu H; Xu B; Xian Q; Tang Z; Shen H
Vaccine; 2012 May; 30(21):3223-30. PubMed ID: 22342709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
